top of page
gradientForSurfBreak.png

Item List

Jun 17, 2025
Morningstar
Materna Medical Announces Ellora™ and Additional Close on $20M Series B2

Materna Medical, Inc., a leading innovator in women's pelvic health solutions, has announced the completion of a recent close within an ongoing $20 million Series B2 financing round. The round welcomed new funds GLIN Impact Capital, Wealthing VC Club, and Citrine Angels, and was led by InnovaHealth Partners and other key existing investors Wavemaker Three-Sixty Health, Kimera Limited, Women's Venture Capital Fund, and Golden Seeds.

Recent Posts

Portfolio Company

Carlsmed.png

CARL Launches Aprevo Cervical Platform for Personalized Spine Surgery ...

Yahoo Finance

Dec 9, 2025

Portfolio Company

Carlsmed.png

Jannine Versi, Co-Founder & CEO of Elektra Health ...

Fitt/Insider

Dec 9, 2025

Portfolio Company

Carlsmed.png

GPs using AI Tool to Identify Skin Cancer
...

BBC

Dec 8, 2025

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page